Table 1.
Variables collected in the COVID-VIT-D trial included in this report
| Demographic and comorbidities | |
| Date of birth | Diabetes (yes/no) |
| Gender (male/female) | Cardiovascular disease (yes/no) |
| Height (cm) | Hypertension (yes/no) |
| Weight (kg) | Asthma (yes/no) |
| COPD (yes/no) | |
| Hospitalisation (clinical and evolutive data) | |
| Hospital admission date | Death date |
| Hospital discharge date | |
| Biochemical and imaging parameters at admission and discharge | |
| Calcidiol (ng/mL) | Interleukin-6 (pg/mL) |
| CRP (mg/dL) | Ferritin (ng/mL) |
| Albumin (g/L) | Calcium (mg/dL) |
| Haemoglobin (g/dL) | Phosphate (mgl/dL) |
| LDH (U/L) | X-Ray/CAT (positive/ doubtful/negative) |
| Leucocytes (No./μL) | |
| Types of drugs received during the hospitalisation | |
| Cholecalciferol (yes/no) | Enoxaparin (yes/no) |
| Azithromycin (yes/no) | Methylprednisolone (yes/no) |
| Ceftriaxone (yes/no) | Dexamethasone (yes/no) |
COPD Chronic obstructive pulmonary, CRP C-reactive protein, CAT Computed axial tomography